AIMI Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - AIM ImmunoTech Inc

Watchlist Manager

Watchlist

Price: 0.595 USD 8.18% Market Closed

Market Cap: $43m

	AIM ImmunoTech Inc OTC:AIMI	US
C	Capitol Federal Financial Inc F:CFW	US
M	Minesto AB XMUN:7MN	SE
I	International Distributions Services PLC SWB:RYE	UK
	Bank of Communications Co Ltd F:C4C	CN
K	Kinross Gold Corp F:KIN2	CA
S	Select Medical Holdings Corp F:S24	US
	Ondas Holdings Inc F:1B8	US
W	WPP PLC XMUN:0WP	UK
	APA Corp (US) F:2S3	US
H	Hang Seng Bank Ltd F:HSB	HK
E	E ON SE XMUN:EOAN	DE

Profitability Summary

AIM ImmunoTech Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-45%

Strong 3Y Average Gross Margin

63%

Declining Gross Margin

56% > -45%

Negative Operating Margin

-13 255%

Negative 3Y Average Operating Margin

-13 851%

Operating Margin is Increasing

-13 504% > -13 255%

Negative Net Margin

-15 861%

Negative 3Y Average Net Margin

-13 016%

Declining Net Margin

-12 363% > -15 861%

Negative Free Cash Flow Margin

-12 881%

Negative 3Y Average Free Cash Flow Margin

-10 545%

Declining Free Cash Flow Margin

-10 917% > -12 881%

Exceptional ROE

251%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-135%

ROIC is Increasing

-283% > 3 606%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.